ADA and chronic lung disease: Collectively, these results demonstrate that genetic removal of IL-6 in Ada-/- mice leads to attenuated pulmonary inflammation, fibrosis and air-space destruction, further implicating IL-6 signaling in mediating aspects of adenosine driven chronic lung disease.